- MarketWatch•14 minutes agoBiogen’s $1.25 billion agreement with Forward Pharma is a very expensive insurance policy on its most valuable drug
Multiple sclerosis drug Tecfidera is Biogen’s largest revenue generator.
- Business Wire•31 minutes agoSiemens Healthineers and Biogen Announce Agreement to Jointly Develop New MRI Tools for Multiple Sclerosis
Siemens Healthineers and Biogen have announced that the companies plan to jointly develop magnetic resonance imaging applications with the intent of quantifying key markers of multiple sclerosis disease activity and progression.
- American City Business Journals•56 minutes ago
Biogen has reached a $1.25 billion settlement and licensing agreement with Danish biotech Forward Pharma to resolve a dispute over a patent on the Cambridge company’s top-selling multiple sclerosis drug. ...
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||285.61 x 100|
|Ask||285.90 x 200|
|Day's Range||281.08 - 286.32|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|